SARS-CoV-2 Initiates Programmed Cell Death in Platelets

Supplemental Digital Content is available in the text. Rationale: Coronavirus disease 2019 (COVID-19) is characterized by increased incidence of microthrombosis with hyperactive platelets sporadically containing viral RNA. It is unclear if SARS-CoV-2 (severe acute respiratory syndrome, corona virus-2) directly alters platelet activation or if these changes are a reaction to infection-mediated global inflammatory alterations. Importantly, the direct effect of SARS-CoV-2 on platelets has yet to be studied. Objective: To characterize the direct SARS-CoV-2–platelet interactions using in vitro studies with purified infectious virions and samples from infected patients. Methods and Results: Platelet RNA analyzed by ARTIC v3 sequencing for SARS-CoV-2 showed presence of fragmented viral genome in all patients with COVID-19. Immunofluorescent imaging of platelets from patients with COVID-19 confirmed presence of SARS-CoV-2 proteins, whereas there was no detection of viral RNA by real-time quantitative polymerase chain reaction. Transmission electron microscopy of platelets incubated with purified SARS-CoV-2 virions demonstrated rapid internalization and digestion leading to distinct morphological changes and resulted in a release of extracellular vesicles. Interactions between SARS-CoV-2 and platelets occurred with or without ACE (angiotensin-converting enzyme) 2 presence as measured by immunofluorescence. Transmission electron microscopy showed that SARS-CoV-2 virions became internalized when they were attached to microparticles, bypassing the need for ACE2. Enrichment analysis of platelet transcriptome from patients with acute COVID-19, compared with those with clinical thrombosis, suggested upregulation of pathways related to virally mediated cell death, specifically necroptosis and apoptosis. Platelets incubated with infectious virus appeared to undergo cell death in 30 minutes postincubation as assessed by transmission electron microscopy and platelets from patients with COVID-19 showed evidence of increased markers of apoptosis and necroptosis by Western blot. Immunofluorescence confirmed colocalization of SARS-CoV-2 with phospho-MLKL (mixed lineage kinase domain-like pseudokinase) and caspase 3 on nonpermeabilized platelets in vitro and in COVID-19 platelets. Conclusions: Platelets internalize SARS-CoV-2 virions, directly or attached to microparticles, and viral internalization leads to rapid digestion, programmed cell death, and extracellular vesicle release. During COVID-19, platelets mediate a rapid response to SARS-CoV-2 and this response can contribute to dysregulated immunity and thrombosis.

[1]  C. Fischbacher,et al.  Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland , 2020, The Lancet Diabetes & Endocrinology.

[2]  S. Woolf,et al.  COVID-19 as the Leading Cause of Death in the United States. , 2020, JAMA.

[3]  V. Thiel,et al.  Coronavirus biology and replication: implications for SARS-CoV-2 , 2020, Nature Reviews Microbiology.

[4]  Robert A. Campbell,et al.  COVID‐19 patients exhibit reduced procoagulant platelet responses , 2020, Journal of Thrombosis and Haemostasis.

[5]  L. Khalki,et al.  Platelets Can Associate With SARS-CoV-2 RNA and Are Hyperactivated in COVID-19 , 2020, Circulation research.

[6]  Benjamin P. Kellman,et al.  SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2 , 2020, bioRxiv.

[7]  M. Moses,et al.  Platelet-derived extracellular vesicles infiltrate and modify the bone marrow during inflammation. , 2020, Blood advances.

[8]  Robert A. Campbell,et al.  Platelet gene expression and function in patients with COVID-19 , 2020, Blood.

[9]  M. Koupenova,et al.  Potential role of platelets in COVID‐19: Implications for thrombosis , 2020, Research and Practice in Thrombosis and Haemostasis.

[10]  Hongzhi Yang,et al.  Migrasome and Tetraspanins in Vascular Homeostasis: Concept, Present, and Future , 2020, Frontiers in Cell and Developmental Biology.

[11]  R. Field,et al.  The SARS-COV-2 Spike Protein Binds Sialic Acids and Enables Rapid Detection in a Lateral Flow Point of Care Diagnostic Device , 2020, ACS central science.

[12]  Leora I. Horwitz,et al.  Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study , 2020, BMJ.

[13]  Zhiliang Gao,et al.  SARS‐CoV‐2 can be detected in urine, blood, anal swabs, and oropharyngeal swabs specimens , 2020, Journal of medical virology.

[14]  Amber Dance What is a cytokine storm? , 2020 .

[15]  Susan Daniel,et al.  Coronavirus membrane fusion mechanism offers a potential target for antiviral development , 2020, Antiviral Research.

[16]  D. Lillicrap Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[17]  R. Lu,et al.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens. , 2020, JAMA.

[18]  G. Herrler,et al.  SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor , 2020, Cell.

[19]  Dengju Li,et al.  Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia , 2020, Journal of Thrombosis and Haemostasis.

[20]  J. Badimón,et al.  Internalization of microparticles by platelets is partially mediated by toll-like receptor 4 and enhances platelet thrombogenicity. , 2019, Atherosclerosis.

[21]  C. Heisenberg,et al.  Migrasomes take center stage , 2019, Nature Cell Biology.

[22]  M. Kozlov,et al.  Migrasome formation is mediated by assembly of micron-scale tetraspanin macrodomains , 2019, Nature Cell Biology.

[23]  Li Yu,et al.  Identification of markers for migrasome detection , 2019, Cell Discovery.

[24]  D. Levy,et al.  The role of platelets in mediating a response to human influenza infection , 2019, Nature Communications.

[25]  A. Barr,et al.  Heparan sulfates are critical regulators of the inhibitory megakaryocyte-platelet receptor G6b-B , 2019, bioRxiv.

[26]  J. Kagan,et al.  Apoptosis and Necroptosis as Host Defense Strategies to Prevent Viral Infection. , 2017, Trends in cell biology.

[27]  Daniel R. Caffrey,et al.  Immunobiology of Long Noncoding RNAs. , 2017, Annual review of immunology.

[28]  J. Freedman,et al.  The role of RNA uptake in platelet heterogeneity , 2017, Thrombosis and Haemostasis.

[29]  Yingying Zhang,et al.  The MLKL Channel in Necroptosis Is an Octamer Formed by Tetramers in a Dyadic Process , 2016, Molecular and Cellular Biology.

[30]  A. Winnicka,et al.  The biology of extracellular vesicles with focus on platelet microparticles and their role in cancer development and progression , 2016, Tumor Biology.

[31]  I. Joosten,et al.  Platelet microparticles inhibit IL-17 production by regulatory T cells through P-selectin. , 2016, Blood.

[32]  Y. Jarajapu,et al.  Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cells. , 2016, European journal of pharmacology.

[33]  M. Gelb,et al.  Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA , 2015, Proceedings of the National Academy of Sciences.

[34]  Y. Li,et al.  Discovery of the migrasome, an organelle mediating release of cytoplasmic contents during cell migration , 2014, Cell Research.

[35]  E. Benjamin,et al.  Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. , 2014, Blood.

[36]  J. Italiano,et al.  The incredible journey: From megakaryocyte development to platelet formation , 2013, The Journal of cell biology.

[37]  M. Alessi,et al.  Endocytosis and intracellular processing of platelet microparticles by brain endothelial cells , 2012, Journal of cellular and molecular medicine.

[38]  R. Koenen,et al.  Microparticles from apoptotic platelets promote resident macrophage differentiation , 2011, Cell Death and Disease.

[39]  B. Cookson,et al.  Apoptosis, Pyroptosis, and Necrosis: Mechanistic Description of Dead and Dying Eukaryotic Cells , 2005, Infection and Immunity.

[40]  A. Grant,et al.  Assessment of platelet activation in several different anticoagulants by the Advia 120 Hematology System, fluorescence flow cytometry, and electron microscopy , 2003, Thrombosis and Haemostasis.

[41]  Matthew Ducar,et al.  Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2* , 2003, The Journal of Biological Chemistry.

[42]  L. Young,et al.  Viruses and apoptosis , 2001, International journal of experimental pathology.

[43]  Nigel M. Hooper,et al.  A Human Homolog of Angiotensin-converting Enzyme , 2000, The Journal of Biological Chemistry.

[44]  S. Ebbe,et al.  SIALIC ACID OF HUMAN BLOOD PLATELETS. , 1964, The Journal of clinical investigation.